6 μg per day). Systemic absorption through damaged skin (e.g. after shaving) is much higher. The BfR therefore announced a warning not to apply an aluminium-containing antiperspirant shortly after shaving the armpit because of the significant contribution to the general aluminium body burden [15]. Aluminium performs no obvious biological function in the human body and there is no evidence to date of aluminium-specific metabolism [16]. However, aluminium SRT1720 mouse will take a number of different routes of absorption and interactions which will now be briefly summarised. In the blood, >90% aluminium
in plasma is associated with transferrin [2], with the approximate concentration of aluminium believed to be ∼1–2 μg/L. The lungs and the bones are considered to be the major deposits in the body. Bone, lung, muscle, liver and brain are described as bearing approximately 60, 25, 10, 3 and 1% of the total body burden of aluminium, respectively [4]. Aluminium concentrations Selleck Fluorouracil are also thought to increase with age [4]. The monocarboxylate transporter, the transferrin receptor shuttle, aluminium citrate and, recently described, ferritin are considered to be the transport routes of aluminium for crossing the blood–brain barrier [5], [7], [8], [9] and [16]. In 2001, Yokel et al. published a half-life of 150 days of aluminium in the
brains of rats following a single parenteral application of an 26aluminium isotope [17]. Monitoring aluminium accumulation
in humans is challenging. Urine and blood plasma analysis can be performed however neither will provide an accurate indication of the total aluminium body burden of an individual. Exley, 2013 best describes the true body burden of aluminium: “for an individual PD184352 (CI-1040) is clearly not yet a quantity which is accessible by conventional means, at least not for a living person. While measurements of body burden are available these are actually indirect estimates of the systemic body burden, for example, the aluminium content of urine. These measurements are particularly helpful in comparing relative changes in the body burden of aluminium between individuals or between populations. They are, however, are less informative about where aluminium is found in the body or its potential for systemic toxicity” [2]. EFSA (The European Food Safety Authority) stated in a recent report [18]: “in view of the cumulative nature of aluminium in the organism after dietary exposure, the Panel considered it more appropriate to establish a tolerable weekly intake (TWI) for aluminium rather than a tolerable daily intake (TDI)… …Based on combined evidence… the Panel established a TWI of 1 mg of aluminium/kg bw/week. Animal studies are the rationale for the definition of this threshold value: “The available studies have a number of limitations and do not allow any dose-response relationships to be established.